Alliance Pharma plc (LON:APH – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as GBX 61.50 ($0.76) and last traded at GBX 61.20 ($0.75), with a volume of 8782805 shares. The stock had previously closed at GBX 61.10 ($0.75).
Alliance Pharma Price Performance
The company has a debt-to-equity ratio of 47.46, a current ratio of 2.93 and a quick ratio of 1.42. The firm has a market capitalization of £330.83 million, a price-to-earnings ratio of -1,020.00, a PEG ratio of 1.04 and a beta of 0.67. The business’s fifty day simple moving average is GBX 48.48 and its 200 day simple moving average is GBX 43.21.
About Alliance Pharma
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.
Further Reading
- Five stocks we like better than Alliance Pharma
- Market Cap Calculator: How to Calculate Market Cap
- Oracle Announces Game-Changing News for the AI Industry
- Quiet Period Expirations Explained
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- The 3 Best Blue-Chip Stocks to Buy Now
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
